• The document outlines an Agreement on Mutual Recognition (MRA) between the European Community and the United States of America concerning conformity assessment activities.It includes general provisions for recognizing conformity assessment bodies, handling designations, suspensions, withdrawals, and information exchanges. It features specific sectoral annexes, notably detailing Pharmaceutical Good Manufacturing Practices (GMPs), which govern the exchange and normal endorsement of official GMP inspection reports (both pre-approval and post-approval) between the regulatory authorities of the two Parties.
Created by Dr. YASSER MEKKY
EN/AR [Auto]
Join Now| # | Content |
|---|---|
| 1 | Module 1: Mutual Recognition Agreements (MRAs) & International Reliance |
| 2 | Module 2: Regulatory Inspections |
| 3 | Module 3: Regulatory Enforcement Actions |
| 4 | Module 4: Regulatory Agency Reporting & Post-Market Surveillance |
| # | Outcomes |
|---|---|
| Mutual recognition agreements, regulatory inspections, enforcement actions, and regulatory reporting learning outcomes focus on how global drug agencies share work, inspect facilities, punish rule breakers, and report data. These competencies teach professionals how to manage cross-border compliance and audits. |
| # | Participants |
|---|---|
| 1 |
R
Regulated Manufacturers
|
| 2 |
C
Conformity Assessment Bodies (CABs)
|
| 3 |
N
National Regulatory Authorities (NRAs)
|
| 4 |
R
Regulatory Inspections
|
| 5 |
E
Enforcement Actions & Reporting
|